NASDA Joins In The Call For Raising THC in Hemp From 0.3% To 1%
AUSTIN – NASDA, is an organization that represents the Commissioners, Secretaries, and Directors of the state departments of agriculture in all fifty states and four U.S. territories. State departments of agriculture are responsible for a wide range of programs including conservation and environmental protection, food safety, combating the spread of plant and animal diseases and fostering the economic vitality of rural communities. The nation’s state agriculture departments have joined the call for raising the THC limit in hemp from 0.3% to a full 1%.
Reporting in Hemp Industry Daily today, says The Hemp Industries Association and other advocates have called a 1% THC limit a necessary change to encourage participation in the hemp sector. The U.S.D.A. can’t raise the THC limit on its own.
“The 1% threshold will help give growers all across the country, especially those growing for CBD, some greater flexibility with variety selection and maximizing CBD percentages before a crop goes hot,” said Rob Richard, president of the Wisconsin Hemp Alliance, said in Hemp Industry Daily.
NASDA members updated their federal hemp strategy in 2019 emphasizing five key principles:
- NASDA supports the production, processing and commercialization of hemp.
- NASDA encourages research in all aspects of hemp from production to finished products.
- NASDA supports consistent model legislation to assist state legislatures in their efforts to enact laws permitting hemp production within their jurisdictions in accordance with the 2018 Farm Bill.
- NASDA supports the development of uniform standards for field sampling and tetrahydrocannabinol (THC) content testing with gas chromatography (GC) methods.
- NASDA encourages the U.S. Food & Drug Administration (FDA), in consultations with states, to develop a model regulatory framework for oversight of the processing of hemp and manufacturing of cannabidiol (CBD) which will protect public health and foster growth in the U.S. hemp industry while remaining consistent with letter and spirit of federal law.
Latest News
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...